Search

You searched for "pain"

405 results found

A guided guide to the guide wire

6 May 2020 | | Endourology and Stones, Technological Developments
The use of guide wires has become a core skill utilised by urologists, especially within the field of endourology. The authors take us through the development of the guide wire and their current use in urology. The history The first...

Dr Glaucomflecken: Stayin’ Alive

1 November 2022 |
Peter Cackett spoke to ophthalmologist and social media sensation Dr Glaucomflecken about his early days in comedy, the role satire can play in impacting medical governance, and where he might take his brand of medical comedy next. It was towards...

MRI screening for prostate cancer: a step towards a ‘prostagram’

7 January 2020 | | Technological Developments, Urologic Oncology
The UK National Screening Committee has been calling for further research into alternative screening tests for prostate cancer. The committee decided against prostate cancer screening using prostate specific antigen (PSA) testing on the basis that “PSA is still a poor...

Virtual and augmented reality in surgery

1 January 2018 | | Technological Developments
Virtual reality (VR) is a three-dimensional, computer generated environment which can be accessed using a virtual reality headset, allowing individuals to immerse themselves in this virtual world. Augmented reality (AR) systems layer virtual information over a live camera feed into...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

7 March 2019 | Awards & Conferences
Partnership with Academia Award Winner: Femeda Ltd Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from the...

Prostate cancer survivorship: a new path for uro-oncology

1 July 2015 | | Urologic Oncology
Over two million people in England have a diagnosis of cancer [1]. Of this figure, over 250,000 have been diagnosed with prostate cancer [2]. However, during the next decade, a rapid increase in the number of new cancer diagnoses, as...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

7 March 2019 | Research & Development
Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from...

How the COVID pandemic has shaped ongoing service delivery at ERIC, The Children’s Bowel & Bladder Charity

6 January 2023 | COVID-19 - Urology News
- CHARITY FOCUS - Like many organisations and charities, COVID-19 generated a rapid period of adaptation and diversification for ERIC, The Children’s Bowel and Bladder Charity. Their Head of Communications, Alina Lynden, explains what this meant for the organisation and...

Prostate cancer

1 July 2015 | | Urologic Oncology
Case 1 What is prostate specific antigen (PSA) and what is its function? According to the ERSPC Trial (at 13 years), what was the number needed to screen and diagnosed to prevent one prostate cancer death and what was the...

Urological trauma – part 2

1 November 2015 | | Trauma and Emergency Urology
Part 1 of this topic is available here. Case 1 A 29-year-old male was attacked and kicked in his left flank. He presented to the emergency department with left flank pain and frank haematuria. He remained haemodynamically stable. 1. What...

Infections and inflammation: Part 3

1 May 2019 | Functional Urology, Infection, Andrology, Trauma and Emergency Urology
See also Part 1 and Part 2 Case 1 You review a man in the Emergency Department with scrotal pain and sepsis. His clinical examination findings are shown. What does this image show? Who was this condition named after? What...

Prostate cancer

8 November 2021 | | Urologic Oncology
Case 1 A 65-year-old man is referred to your two-week wait (2WW) clinic with a PSA of 7.0ng/mL. He has no lower urinary tract symptoms (LUTS), no past medical history, no family history of prostate cancer (PCa) and his performance...